Image

Finishing HIV Project

Finishing HIV Project

Recruiting
18-54 years
Male
Phase N/A

Powered by AI

Overview

This study aims to learn how to help enable healthy behaviors and lower the risk of HIV among Latinx Men.

Eligibility

Inclusion Criteria

  1. Provision of signed and dated informed consent form
  2. Stated willingness to comply with all study procedures and availability for the duration of the study
  3. Being 18 to 54 years of age
  4. Being a cis-gender male
  5. Self-report one or more of the following behaviors and health conditions in the last 6 months which meet the Centers for Disease Control and Prevention (CDC) clinical guidelines for PrEP eligibility
    • Diagnosed with bacterial sexually transmitted infection (e.g., syphilis, gonorrhea, or chlamydia)
    • Sex with a partner who is living with HIV
    • Sex without a condom with two or more partners whose HIV status were unknown
    • Injection drug use and sharing injection equipment
  6. Self-reported status as HIV negative
  7. Willing to be tested for HIV

Exclusion Criteria

  1. Display diminished capacity to consent because of:
    • An inability to provide informed consent (e.g., cognitive impairment)
    • Severe psychiatric symptoms (e.g., mania, psychosis) that impair capacity to provide informed consent, as assessed by interviewers with Collaborative Institutional Training Initiative (CITI) Human Subjects Research and National Institutes of Health (NIH) Good Clinical Practice training
  2. <18 years old or >54 years old
  3. Self-reported living with HIV
  4. Reactive HIV test (for "Amigx" seeds or "Yo Quiero" control participants)
  5. Refusal of HIV test
  6. Identifies as Non-Latinx
  7. Individuals enrolled in other PrEP initiation interventions
  8. Individuals with an active PrEP prescription in the last 6-months (oral or injectable)

Study details
    Hiv

NCT06406049

University of Miami

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.